Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin.

Journal of infection in developing countries - 15 Nov 2013

Sadeq Refaat, Mohtady Heba, Al Badawy Nissreen, Ibrahim Salwa, Omar Abdul Rahman, Husseiny Mohamed I, El Zowalaty Mohamed

Abstract excerpt

INTRODUCTION: Hepatitis C virus (HCV) infections remain an increasingly prevalent and emergent health problem worldwide, causing a wide spectrum of liver diseases. Combination therapy with pegylated interferon (PEG-IFN) of peginterferon alfa-2a and oral ribavirin is currently recognized as the standard treatment of chronic HCV infection. Several complex immunological mechanisms are involved during the course of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Egypt

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon-gamma

Share to Leukocytes, Mononuclear

Share to Myxovirus Resistance Proteins

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 24240045
DOI: 10.3855/jidc.2937

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin.PMID 24240045Read ↗

Activation of Type I and Type III Interferons in Chronic Hepatitis C.Semantic proximity Read ↗

Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.Semantic proximity Read ↗

MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.Semantic proximity Read ↗

Genetic influence of IFN-γ gene polymorphisms on hepatitis C progression and recovery.Semantic proximity Read ↗

Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.Semantic proximity Read ↗

Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting AntiviralsSemantic proximity Read ↗

Association of IFN-γ and IFN-γ Receptor-1 Genes Polymorphisms with Hepatitis C Virus Infection Chronicity and Severity in Pakistani Patients.Semantic proximity Read ↗

Deciphering the Significance of Plasma Chemokines as Prognostic Biomarkers in Pegylated IFN-Α-2a /Ribavirin-Treated Chronic Hepatitis C Genotype 4 Patients.Semantic proximity Read ↗

Relationship of interferon-γ-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4.Semantic proximity Read ↗

Association of an IFN-γ variant with susceptibility to chronic hepatitis B by the enhancement of HBV DNA replication.Semantic proximity Read ↗

Interferon Lambda: Opportunities, Risks, and Uncertainties in the Fight Against HCVSemantic proximity Read ↗

Interferon-γ inducible protein-10 and interleukin 28B gene polymorphism as predictive markers for genotype 4 hepatitis C virus treatment response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.